The Journal of Neuroscience, August 1, 1999, 19(15):6446-6456
Bcl-2 Overexpression Does Not Protect Neurons from Mutant
Neurofilament-Mediated Motor Neuron Degeneration
Megan K.
Houseweart1, 2 and
Don W.
Cleveland1, 2, 3, 4
1 Ludwig Institute for Cancer Research,
2 Program in Biomedical Sciences, 3 Division of
Cellular and Molecular Medicine, and 4 Department of
Neuroscience, University of California at San Diego, La Jolla,
California 92093
Transgenic mice with a point mutation in the light neurofilament
gene develop amyotrophic lateral sclerosis-like motor neuron disease characterized by selective spinal motor neuron loss,
neurofilamentous accumulations, and severe muscle atrophy. To test
whether the large motor neurons at risk in this disease could be
protected from mutant neurofilament-mediated killing, these mice were
bred to mice overexpressing the human Bcl-2
proto-oncogene. Elevated levels of Bcl-2 increased the numbers of motor
and sensory axons surviving after the developmental period of naturally
occurring cell death but did not greatly reduce the number of
degenerating axons or protect the large motor neurons from mutant
neurofilament-mediated death.
Key words:
Bcl-2; amyotrophic lateral sclerosis; transgenic mice; motor neuron; cell death; neurofilament
Copyright © 1999 Society for Neuroscience 0270-6474/99/19156446-11$05.00/0